Document Detail


Facial resurfacing for nonmelanoma skin cancer prophylaxis.
MedLine Citation:
PMID:  16924046     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To determine the effect of facial skin resurfacing for treatment of actinic keratoses (AKs) and prophylaxis against new primary basal and squamous cell carcinomas in individuals with previous nonmelanoma skin cancer (NMSC) or severe photodamage. DESIGN: Randomized, prospective 5-year trial. SETTING: Dermatology and otolaryngology clinics of a Veterans Affairs hospital. PATIENTS: Thirty-four patients with a history of facial or scalp AKs or basal or squamous cell carcinoma were enrolled. Five of 7 eligible patients who declined study-related treatment were used as controls. Twenty-seven patients were randomized to 3 treatment arms; 3 patients were discontinued from the study. INTERVENTIONS: Carbon dioxide laser resurfacing, 30% trichloroacetic acid peel, or 5% fluorouracil cream applied twice daily for 3 weeks. MAIN OUTCOME MEASURES: Reduction in the number of AKs was measured 3 months after treatment. The incidence of new NMSC in treated areas was assessed between January 1, 2001, and June 30, 2005. Times from baseline to diagnosis of first skin cancer were compared between the treatment and control groups. RESULTS: Treatment with fluorouracil, trichloroacetic acid, or carbon dioxide laser resulted in an 83% to 92% reduction in AKs (P< or =.03), a lower incidence of NMSC compared with the control group (P<.001), and a trend toward longer time to development of new skin cancer compared with the control group (P=.07). However, no significant differences were noted among the treatment groups. CONCLUSION: All 3 modalities demonstrated benefit for AK reduction and skin cancer prophylaxis compared with controls and warrant further study in a larger trial.
Authors:
Basil M Hantash; Daniel B Stewart; Zachary A Cooper; Wingfield E Rehmus; R James Koch; Susan M Swetter
Related Documents :
2056316 - Spinal mediation of thermally induced sweating.
16173416 - Lesional characteristics and histopathology in paucibacillary leprosy patients with 2 o...
9092746 - Treatment of melasma with jessner's solution versus glycolic acid: a comparison of clin...
20952896 - Autologous miniature skin punch grafting in vitiligo.
10360226 - Pancreas divisum.
19476116 - Comparison of intracoronary adenosine and isosorbide dinitrate on no-reflow/slow flow d...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Archives of dermatology     Volume:  142     ISSN:  0003-987X     ISO Abbreviation:  Arch Dermatol     Publication Date:  2006 Aug 
Date Detail:
Created Date:  2006-08-22     Completed Date:  2006-09-11     Revised Date:  2008-03-17    
Medline Journal Info:
Nlm Unique ID:  0372433     Medline TA:  Arch Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  976-82     Citation Subset:  AIM; IM    
Affiliation:
Department of Dermatology, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Carbon Dioxide
Carcinoma, Basal Cell / pathology,  prevention & control
Carcinoma, Squamous Cell / pathology,  prevention & control
Disease-Free Survival
Drug Administration Schedule
Face
Female
Fluorouracil / administration & dosage
Humans
Keratolytic Agents / administration & dosage*
Keratosis / pathology,  prevention & control*
Laser Therapy, Low-Level*
Male
Middle Aged
Prospective Studies
Scalp
Severity of Illness Index
Skin Neoplasms / pathology,  prevention & control*
Treatment Outcome
Trichloroacetic Acid / administration & dosage
Chemical
Reg. No./Substance:
0/Keratolytic Agents; 124-38-9/Carbon Dioxide; 51-21-8/Fluorouracil; 76-03-9/Trichloroacetic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Presymptomatic treatment of neonatal guanidinoacetate methyltransferase deficiency.
Next Document:  Skin rejuvenation using intense pulsed light: a randomized controlled split-face trial with blinded ...